title: Future challenges for health economics and health technology assessment of biological drugs.
authors.forename: László
authors.initials: L
authors.lastname: Gulácsi
mesh_terms: D001688:Biological Products / Q000191:economics* / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D006801:Humans; D015994:Incidence; D010349:Patient Compliance; D015995:Prevalence; D016032:Randomized Controlled Trials as Topic; D012216:Rheumatic Diseases / Q000188:drug therapy; D013673:Technology Assessment, Biomedical
chemical_list: D001688:Biological Products
references.citation: Eur J Health Econ. 2010 Jan;10 Suppl 1:S35-40
references.pmid: 20012135
references.citation: Eur J Health Econ. 2008 Jan;8 Suppl 2:95-106
references.pmid: 18157559
references.citation: Semin Arthritis Rheum. 2009 Apr;38(5):396-402
references.pmid: 18336875
references.citation: Eur J Health Econ. 2008 Jan;8 Suppl 2:S49-60
references.pmid: 18157732
references.citation: Eur J Health Econ. 2006 Dec;7(4):223-4
references.pmid: 17077979
references.citation: Int J Technol Assess Health Care. 2004 Summer;20(3):337-41
references.pmid: 15446763
references.citation: Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:120-6
references.pmid: 19500441